Lv2
122 积分 2025-10-06 加入
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
16天前
已完结
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
1个月前
已完结
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
1个月前
已完结
Bioresponsive nanoreactor initiates cascade reactions for tumor vascular normalization and lactate depletion to augment immunotherapy
1个月前
已完结
Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC
1个月前
已完结
Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
1个月前
已完结
Light-Responsive conjugated polymer nanoparticles with Spatial-Controlled camptothecin release via π-π stacking for improved Combinatorial therapy of breast cancer
1个月前
已关闭
Imaging hypoxia and tumor vascular normalization
1个月前
已关闭
Elements of cancer immunity and the cancer-immune set point
1个月前
已完结
皖公网安备34019202002308
